Finance and Accounting for Bioscience: CPE Accredited Forum for Emerging Biotechs on September 24-25, 2026 in Boston, United States

The CPE-accredited Finance and Accounting for Bioscience conference gathers CFOs, Chief Accountants, Controllers, and senior-level finance and accounting leaders representing the spectrum of life sciences organizations in various stages of product lifecycles, from innovative clinical and pre-clinical biotechs through mature commercial-stage bio/pharmaceutical companies, for two days of learning, networking, and strategic collaboration.

The event's dual-track format allows attendees to select content aligned with their organization's stage: the Pre-Commercial Track focusing on clinical trial finance and commercialization preparation, or the Commercial Track addressing revenue management, pricing, contracting, and strategic managed markets finance.

Featured Sessions:

- SEC and FASB Town Hall

- CFO Panel: Redefining Financial Leadership for Organizational Success

- Closed-Door Executive Think Tank [Industry-Only]

- Navigating Clinical Trials Finance: Accruals, Automation, and AI Integration

- Controllership Panel: Driving Operational Excellence in a Transforming Landscape

- Biotech Financing Insights: Navigating Dynamic Capital Markets

- Optimizing ERP Systems: Tools and Strategies for Biotech Growth

With CPE credits available and 12 months of post-event access to session recordings, this forum provides both immediate learning and long-term professional development value. Early bird rates and group discounts are available! View the complete agenda and secure your place at https://informaconnect.com/finance-bioscience-east/

Booking: https://go.evvnt.com/3690205-2?pid=10008

Date and Time: On Thu, 24 Sep 2026 07:00 - Fri, 25 Sep 2026 16:00

Venue Details: Sheraton Boston Hotel, 39 Dalton Street, Boston, Massachusetts, 02199, United States

Category: Conferences | Science, Health and Medicine | Pharmaceuticals